Ekso Bionics Holdings Statistics
Total Valuation
EKSO has a market cap or net worth of $13.92 million. The enterprise value is $11.98 million.
Important Dates
The next estimated earnings date is Monday, March 3, 2025, after market close.
| Earnings Date | Mar 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EKSO has 22.00 million shares outstanding. The number of shares has increased by 29.99% in one year.
| Current Share Class | 22.00M |
| Shares Outstanding | 22.00M |
| Shares Change (YoY) | +29.99% |
| Shares Change (QoQ) | +11.45% |
| Owned by Insiders (%) | 3.58% |
| Owned by Institutions (%) | 7.98% |
| Float | 17.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| Forward PS | 0.57 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.43.
| Current Ratio | 2.81 |
| Quick Ratio | 2.03 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.32 |
Financial Efficiency
Return on equity (ROE) is -73.89% and return on invested capital (ROIC) is -33.21%.
| Return on Equity (ROE) | -73.89% |
| Return on Assets (ROA) | -24.17% |
| Return on Capital (ROIC) | -33.21% |
| Revenue Per Employee | $245,583 |
| Profits Per Employee | -$154,597 |
| Employee Count | 72 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.62 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.86% in the last 52 weeks. The beta is 1.48, so EKSO's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -69.86% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 1.04 |
| Relative Strength Index (RSI) | 45.20 |
| Average Volume (20 Days) | 2,932,249 |
Short Selling Information
The latest short interest is 240,337, so 1.09% of the outstanding shares have been sold short.
| Short Interest | 240,337 |
| Short Previous Month | 124,633 |
| Short % of Shares Out | 1.09% |
| Short % of Float | 1.39% |
| Short Ratio (days to cover) | 1.41 |
Income Statement
In the last 12 months, EKSO had revenue of $17.68 million and -$11.13 million in losses. Loss per share was -$0.64.
| Revenue | 17.68M |
| Gross Profit | 9.17M |
| Operating Income | -11.68M |
| Pretax Income | -12.42M |
| Net Income | -11.13M |
| EBITDA | -10.04M |
| EBIT | -11.68M |
| Loss Per Share | -$0.64 |
Full Income StatementBalance Sheet
The company has $8.29 million in cash and $6.35 million in debt, giving a net cash position of $1.95 million or $0.09 per share.
| Cash & Cash Equivalents | 8.29M |
| Total Debt | 6.35M |
| Net Cash | 1.95M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 14.87M |
| Book Value Per Share | 0.68 |
| Working Capital | 13.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.00 million and capital expenditures -$59,000, giving a free cash flow of -$10.06 million.
| Operating Cash Flow | -10.00M |
| Capital Expenditures | -59,000 |
| Free Cash Flow | -10.06M |
| FCF Per Share | -$0.46 |
Full Cash Flow StatementMargins
Gross margin is 51.84%, with operating and profit margins of -66.05% and -62.95%.
| Gross Margin | 51.84% |
| Operating Margin | -66.05% |
| Pretax Margin | -62.95% |
| Profit Margin | -62.95% |
| EBITDA Margin | -56.76% |
| EBIT Margin | -66.05% |
| FCF Margin | n/a |
Dividends & Yields
EKSO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.99% |
| Shareholder Yield | -29.99% |
| Earnings Yield | -79.94% |
| FCF Yield | -72.22% |
Analyst Forecast
The average price target for EKSO is $5.50, which is 768.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.50 |
| Price Target Difference | 768.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on March 25, 2020. It was a reverse split with a ratio of 0.0666666:1.
| Last Split Date | Mar 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.0666666:1 |
Scores
EKSO has an Altman Z-Score of -11 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11 |
| Piotroski F-Score | 4 |